{"name":"Xiaohua Wu","slug":"xiaohua-wu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOdjFHdEpSSU1manRob3BTbFpDQ2M2dlZGSXNWYkpLYlF3R3FGUXdzb1BEOEhuVlVwY0tDUVpWeDBqRDBQRGpJQmEwakxXQkx1MUlqRlBWMFVtOGFGRnFOTG9CaXhtb3VLb0t2bC1zbGQ4LUpqWFJSQ1pDcmJLX1Y3WHUtckFJakRSUzM5a0hpREp5Nk1DRHo4UW54QVEyeXFKUGFGUTBoZGlDR1RHSGk3NG9PSXZmQ0xsN2dmbm9wRWJkX1VQTS1qUA?oc=5","date":"2025-07-21","type":"pipeline","source":"The ASCO Post","summary":"Camrelizumab Plus Famitinib vs Camrelizumab Alone in Recurrent or Metastatic Cervical Cancer - The ASCO Post","headline":"Camrelizumab Plus Famitinib vs Camrelizumab Alone in Recurrent or Metastatic Cervical Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxObWJxVXREU1ctTVVSRm8wa2FDd3lrV2I0aXQ4VkR4dVJuZGs0X01SX1RBeFFHS3U1YXcxTFNlbWt0SGh5Vl9pYUNxeDV2QzNOZEIyd0ZYdno2NWhDNHRfSVN5VGUzUndPQWMyWm1SNDdXR1drb0RHTlBLZFVmTnc0V1VNTk05YkYzelJJRkVvM2Rxd2E3MHNGQndrLU8?oc=5","date":"2025-05-16","type":"pipeline","source":"Yicai Global","summary":"China Decoupling Risks Spike in US Drug Costs - Yicai Global","headline":"China Decoupling Risks Spike in US Drug Costs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5zTWpWQ0tpTjBaV2k1MnhhTnp6NEo1RkdqTERBTllRV2k3WUZ4eU5aVUpCaHVQZGdLbFBBWGtxRC1xamxtelhKQXBqWEVORTRLVXVlZzdIRm5LSGN0SUdn?oc=5","date":"2024-10-20","type":"pipeline","source":"Nature","summary":"ER stress-induced LINC00173 promotes the apoptosis of ovarian granulosa cells by regulating the HRK/PI3K/AKT pathway in polycystic ovary syndrome - Nature","headline":"ER stress-induced LINC00173 promotes the apoptosis of ovarian granulosa cells by regulating the HRK/PI3K/AKT pathway in ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1ZNXF6YndEY0JrMV96MnE4M3JraVBQcXc5NlJ3Njc0MUpmblVfX2h4MUduVG90Y0trSFJJS1hQdTJEbzNxakJvRlc5MUkxQjl2RVNpbUdXdGdWd0d2Z2FxaWlkQ2t6Um1vNklYUA?oc=5","date":"2022-06-29","type":"regulatory","source":"팜뉴스","summary":"Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China - 팜뉴스","headline":"Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9pWm5KbDFaMUs5S1dVS29BQnpSbXQ5dFQ4Uk5hR0lINGRyMWdtWVpCbGF4X1RlSVRuWnhVdUxWWENQdEx0dW50X1czM3dMNVhWenl3U3FkWEFrMUkweGN2OC1MdU9LZ1RfZURkeHRhMDRRYXVJaXNVcw?oc=5","date":"2022-04-15","type":"pipeline","source":"University of Hawaii System","summary":"UH researcher identifies peptide active against certain cancers - University of Hawaii System","headline":"UH researcher identifies peptide active against certain cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUUcwMzdBZExfSGlkbGU0UkMtRXRMY0RqMXpwcnhvcjJNS1Y1OHIwQjJCcU54MHlQSGNMQzJFZS1BV184bExPMTM0TGwyWEJjQ0xHX0VmV19ZWk4tcGdUVVFpOUFWd2dRc0hfR3c3dWU1NWdvYW0xcmFiamJ1R1A0SVYtSzB1OUc4eHJoc0dyb0hGM1JYWkZhRnUyb0p6cFNFWXlIZF9wZGQ?oc=5","date":"2017-02-08","type":"pipeline","source":"University of Hawaii at Hilo","summary":"Spring 2017: UH Hilo welcomes new faculty and staff - University of Hawaii at Hilo","headline":"Spring 2017: UH Hilo welcomes new faculty and staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBFSUpYS0dpMU9BcDJQYkdoZjQxdnpYLWNhaDVNRnY1SDlJZVhNczlSX1BHU2dySEY5eUVIWVdnNWs3NGwtQlJRLTh2d05qM0tqekI0?oc=5","date":"2016-05-03","type":"pipeline","source":"Nature","summary":"A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression - Nature","headline":"A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expressi","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}